Genomic Biomarkers to Predict Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS)

Authors
Category Primary study
JournalBlood
Year 2017
This article has no abstract
Epistemonikos ID: a755b70182092354b4729b4aa4d5bac307653334
First added on: Feb 08, 2025